Fulcrum Therapeutics, Inc. (FULC)
NASDAQ·Healthcare·Biotechnology
$3.65
-2.02%
Mkt Cap $201.29M
Analyst Ratings
Buy
0
Hold
3
Sell
2
Price Target (26 analysts)
$20.67
Range $10.00 – $25.00
Implied Upside
+467.1%
Consensus $20.67 vs current $3.65
NASDAQ·Healthcare·Biotechnology
$3.65
-2.02%
Mkt Cap $201.29M
Buy
0
Hold
3
Sell
2
Price Target (26 analysts)
$20.67
Range $10.00 – $25.00
+467.1%
Consensus $20.67 vs current $3.65